Instead of popping a pill every day, people might soon control "bad" LDL cholesterol by getting an injection at their doctor's office two or three times a year. Researchers testing a new injectable drug called Inclisiran found it cut LDL cholesterol by half or more. According to early clinical trial data, the effect could last for four to six months. Study presenter Dr. Kausik Ray is a professor of public health at Imperial College London in England. According to UPI, Dr. Ray said Inclisiran produced "significant and durable reductions in LDL cholesterol, and thus could potentially impact cardiovascular events." Another phase of research is needed before Inclisiran can receive U.S. Food and Drug Administration approval. Statin pills like Lipitor and Crestor are the current gold standard for treating high cholesterol, but heart doctors say they have their limits.The trial results were presented Tuesday at the American Heart Association annual meeting in New Orleans.
